Integer Holdings Corporation
NYSE:ITGRMedical - Devices
+$1.16 today
- Market cap
- $4.32B
- Beta
- 0.65
- P/E (TTM)
- 21.9
- EPS (TTM)
- $4.14
Volume 0.80M
Average 0.54M
ITGR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Integer Holdings CorporationNYSE: ITGR
Research & Development · Q2 FY2026 · quarter ended Jul 2026
Research & development declines year over year
Q2 FY2026 research & development of $11.28M fell 20.8% year over year, behind the -4.7% change in trailing-twelve-month research & development. Sequentially, it fell 30.6% from the prior quarter. Over 3 fiscal years it compounded at -8.1% a year.
Context
- Research & development amounted to 2.5% of revenue in FY2025, down 0.6 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -20.8% toward the trailing-twelve-month pace of -4.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 46.35M USD
- Year-over-year change
- -13.2%
- 4-year CAGR
- -2.8%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 46.35M | -13.2% |
| FY2024 | 2024-12-31 | 53.43M | -13.8% |
| FY2023 | 2023-12-31 | 61.97M | +3.7% |
| FY2022 | 2022-12-31 | 59.76M | +15.0% |
| FY2021 | 2021-12-31 | 51.99M | — |
Research & Development vs competitors
How ITGR compares with its peers on the latest reported figures
- ITGR's LTM Jul 2026 research & development of $48.58M is the 6th highest of the 10 companies compared; the peer median is $59.46M.
- Its year-over-year change of -4.7% is the 5th highest of 7, against a peer median of +3.5%.
- Research & development amounts to 2.6% of revenue for ITGR, versus a peer median of 7.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $381.91M | -11.4% | +39.8% | 696.2% | |
| LTM Sep 2026 | $202.57M | +14.5% | +6.0% | 13.4% | |
| LTM Jun 2026 | $99.68M | -9.7% | +14.5% | 11.1% | |
| LTM Mar 2026 | $73.13M | +11.5% | +35.0% | 22.7% | |
| LTM Jun 2026 | $59.46M | -4.4% | +0.6% | 4.4% | |
| LTM Jul 2026 | $48.58M | -4.7% | -8.1% | 2.6% | |
| LTM Mar 2026 | $33.1M | +17.2% | -7.3% | 7.2% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ITGR) | $59.46M | +3.5% | +10.3% | 7.2% | |
Competitors are the stored peer set for ITGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.33B | 1.56B | 1.72B | 1.85B |
| Cost of Revenue | 884.11M | 984.63M | 1.14B | 1.26B | 1.42B |
| Gross Profit | 336.97M | 346.65M | 411.52M | 461.18M | 425.81M |
| Gross Margin | 27.6% | 26.0% | 26.5% | 26.9% | 23.1% |
| Research & Development | 51.99M | 59.76M | 61.97M | 53.43M | 46.35M |
| Selling, General & Admin | 141.69M | 157.36M | 171.47M | 184.33M | 162.59M |
| Operating Expenses | 201.26M | 233.97M | 248.2M | 252.95M | 216.55M |
| Depreciation & Amortization | 81.37M | 91.99M | 98.84M | 111.03M | 130.67M |
| EBITDA | 224.43M | 222.84M | 277.56M | 334.27M | 298.38M |
| EBITDA Margin | 18.4% | 16.7% | 17.8% | 19.5% | 16.2% |
| Operating Income | 135.71M | 112.68M | 163.32M | 208.24M | 209.27M |
| Operating Margin | 11.1% | 8.5% | 10.5% | 12.1% | 11.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 31.63M | 37.27M | 53.37M | 56.37M | 42.31M |
| Other Income / Expenses | (34.65M) | (44M) | (57.94M) | (60.68M) | (83.87M) |
| Income Before Tax | 101.06M | 68.68M | 105.38M | 147.56M | 125.4M |
| Pre-Tax Margin | 8.3% | 5.2% | 6.8% | 8.6% | 6.8% |
| Income Tax Expense | 8.04M | 8.93M | 16.24M | 26.51M | 22.57M |
| Net Income | 96.81M | 66.38M | 90.65M | 119.9M | 102.76M |
| Net Margin | 7.9% | 5.0% | 5.8% | 7.0% | 5.6% |
| EPS (Basic) | 2.82 | 1.97 | 2.72 | 3.60 | 2.96 |
| EPS (Diluted) | 2.80 | 1.96 | 2.69 | 3.40 | 2.89 |
| Weighted Avg Shares | 32.99M | 33.13M | 33.32M | 33.6M | 34.74M |
| Weighted Avg Shares (Diluted) | 33.26M | 33.36M | 33.76M | 35.65M | 35.59M |
Integer Holdings Corporation
NYSE:ITGR
Intrinsic Alpha fair value
Locked
Current Price
$126.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.